Westwood Holdings Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-66,183
Closed -$4.12M 413
2015
Q3
$4.12M Sell
66,183
-64,968
-50% -$5.12M 0.04% 252
2015
Q2
$10.6M Buy
+131,151
New +$10.2M 0.08% 160

Other funds holding XBI

Westwood Holdings Group's XBI Position: Q4 2015 in Review

Westwood Holdings Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2015, closing a stake of 66,183 shares — an estimated $4.12M sold.

Westwood Holdings Group first reported a position in XBI in Q2 2015 and held it in 2 quarters. The position peaked at $10.6M in Q2 2015. 199 funds tracked by Wall St. Rank hold XBI as of Q4 2015.

  • Westwood Holdings Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2015 after selling out during the quarter.
  • Westwood Holdings Group sold 66,183 State Street SPDR S&P Biotech ETF shares in Q4 2015, an estimated $4.12M.
  • Westwood Holdings Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 2 quarters.
  • Westwood Holdings Group's State Street SPDR S&P Biotech ETF position peaked at $10.6M in Q2 2015.
  • 199 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2015.

Based on Westwood Holdings Group's 13F filing for Q4 2015, filed 16 Feb 2016.